Forma Therapeutics Holdings, Inc. Common Stock (FMTX)

FMTX was delisted on the 13th of October, 2022.

• Market cap: $958M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Forma Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. The firm's pipeline products are Etavopivat, FT-7051, FT-8225, and others.

Employees: 189